Shaked Ari-Lev

Ramat Gan, TA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

THERAPY IN PATIENTS AFFECTED BY BREAST AND PROSTATE CANCER

THERAPY IN PATIENTS AFFECTED BY BREAST AND PROSTATE CANCER

Journal: Harefuah

Published: July 24, 2025

Utilizing Immuno-Oncology registry data for enhanced non-small cell lung cancer treatment predictions.

Utilizing Immuno-Oncology registry data for enhanced non-small cell lung cancer treatment predictions.

Journal: JAMIA open

Published: April 03, 2025

Associations Between Anxiety or Depression Diagnosis and Immune Checkpoint Inhibitor Outcomes.

Associations Between Anxiety or Depression Diagnosis and Immune Checkpoint Inhibitor Outcomes.

Journal: Cancer medicine

Published: March 05, 2025

Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.

Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 26, 2024

CANCER SURVIVORS - QUESTIONS, CONSIDERATIONS AND POSSIBLE SOLUTIONS

CANCER SURVIVORS - QUESTIONS, CONSIDERATIONS AND POSSIBLE SOLUTIONS

Journal: Harefuah

Published: November 21, 2024

Targeting the Gut Microbiome to Improve Immunotherapy Outcomes: A Review.

Targeting the Gut Microbiome to Improve Immunotherapy Outcomes: A Review.

Journal: Integrative cancer therapies

Published: September 03, 2024

Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials.

Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials.

Journal: Cancers

Published: April 08, 2024

The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study.

The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study.

Journal: Cancer

Published: December 05, 2022

The Risk of Opportunistic Infections and the Role of Antibiotic Prophylaxis in Patients on Checkpoint Inhibitors Requiring Steroids.

The Risk of Opportunistic Infections and the Role of Antibiotic Prophylaxis in Patients on Checkpoint Inhibitors Requiring Steroids.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: February 22, 2022

Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy.

Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy.

Journal: Journal for immunotherapy of cancer

Published: March 19, 2021

Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma.

Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma.

Journal: Cancers

Published: June 20, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026